Brand Intelligence Graphcompany
Company Overview
About Medtronic
Medtronic plc is the world's largest medical device company, founded in 1949 by Earl Bakken and Palmer Hermundslie in a Minneapolis, Minnesota garage—where Bakken invented the first wearable external pacemaker—and now incorporated in Ireland with operational headquarters in Dublin, trading on NYSE (MDT). The company generated approximately $32.4 billion in revenues for fiscal year 2024 (ending April 26, 2024) under CEO Geoff Martha, spanning cardiovascular, neuroscience, surgical, and diabetes therapy technologies. Medtronic's 2015 acquisition of Covidien for $49.9 billion—at the time the largest medical device merger in history—added surgical instruments, patient monitoring, and respiratory interventions while enabling Irish incorporation that reduced the company's effective tax rate. In 2024, Medtronic announced the spin-off of its Patient Monitoring & Respiratory Interventions segment as an independent company (NewCo), sharpening focus on higher-margin, high-growth therapy areas.
Business Model & Competitive Advantage
Medtronic's cardiovascular portfolio—the largest revenue contributor—includes implantable cardiac defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, cardiac ablation systems (Affera and Arctic Front cryoablation), transcatheter heart valves (Evolut TAVR competing with Edwards Lifesciences), and electrophysiology mapping systems. The neuromodulation portfolio includes deep brain stimulation (DBS) systems for Parkinson's disease and essential tremor, spinal cord stimulation for chronic pain, and neurovascular intervention catheters. Hugo, Medtronic's soft-tissue robotic-assisted surgery system, received CE Mark and international approvals and is being deployed to challenge Intuitive Surgical's da Vinci monopoly in soft-tissue robotic surgery—a market Medtronic is pursuing aggressively given its global hospital relationships and installed base of surgical products.
Competitive Landscape 2025–2026
In 2025-2026, Medtronic competes with Abbott Laboratories (cardiac rhythm), Edwards Lifesciences (structural heart valves), Boston Scientific (cardiac electrophysiology, endoscopy), Stryker (neurosurgery, spinal), and Intuitive Surgical (robotic surgery) across its major therapy areas. The diabetes segment's MiniMed 780G automated insulin delivery system competes with Insulet's Omnipod and Tandem Diabetes Care's Control-IQ in the closed-loop insulin pump market, with continuous glucose monitor integration through partnerships with Dexcom and Abbott. The company's global presence—generating approximately 45% of revenues outside the United States—provides diversification but also currency translation headwinds that have pressured reported growth versus constant-currency performance.
The Medtronic Story
Founders
Recent Activity
View all →Company Timeline
Major milestones in Medtronic's journey
Leadership Team
Meet the leaders behind Medtronic
Geoff S. Martha
Geoff Martha was named CEO in April 2020 after joining Medtronic in 2011 and holding various enterprise-level leadership roles in strategy, corporate development, and oversight of business units. His total compensation for fiscal 2025 was $23.3 million, reflecting strong company performance and strategic execution. Martha leads Medtronic's focus on accelerating innovation, expanding market positions, and driving operational excellence.
Thierry Piéton
Thierry Piéton serves as EVP and CFO, overseeing all financial operations, investor relations, treasury, tax, and financial planning for Medtronic's $33+ billion annual revenue operation. He manages capital allocation, financial reporting, and strategic financial planning supporting the company's long-term growth objectives.
Sean Salmon
Sean Salmon leads Medtronic's largest business segment, the Cardiovascular Portfolio, which includes cardiac rhythm management, structural heart therapies, coronary and peripheral vascular interventions, and mechanical circulatory support. He drives innovation and market expansion across cardiovascular technologies that serve millions of patients with heart disease globally.
Gregory Smith
Gregory Smith oversees Medtronic's global manufacturing operations, supply chain management, logistics, and quality systems across the company's worldwide network of production facilities. He ensures reliable supply of life-saving medical devices while driving operational efficiency, quality excellence, and supply chain resilience.
Lars Reger
Lars Reger leads Medtronic's technology strategy, R&D investments totaling $2.7 billion annually, and innovation roadmap across all business segments. He drives the company's focus on AI, robotics, digital health, and advanced medical technologies that define the future of medical device innovation.
Key Differentiators
Market Leader
Medtronic is recognized as a market leader in the Healthcare Tech sector, demonstrating strong industry presence and customer trust.
Enterprise Scale
With $32.4B in revenue, Medtronic operates at enterprise scale with proven market validation.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
GE HealthCare
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin
Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,
Biogen
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and com
Danaher Corporation
Danaher Corporation is a Washington, D.C.-based global science and technology company — publicly traded on the New York Stock Exchange (NYSE: DHR) as an S&P 500 Health Care component — developing, man
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Medtronic with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Medtronic? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Medtronic Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Medtronic vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →